Mitochondrial Disease

Mitochondrial disease is a qualifying condition for Georgia’s Medical Cannabis Patient Registry. This guide is for Georgia adults considering a physician evaluation. It explains eligibility, research limitations, safety questions and current card steps, so you can prepare for the visit while continuing specialist care. Medical marijuana is not a cure for primary mitochondrial disease, and an evaluation does not guarantee a treatment benefit or certification.

$100 · Private 15-minute phone consultation with a Georgia-licensed physician. GMMC serves adults age 18 and older throughout Georgia.

Book a $100 Consultation

Medical marijuana for mitochondrial disease: start with an evaluation

If you have a diagnosed mitochondrial disease and want to discuss medical cannabis eligibility, GMMC offers an adult consultation from home. You do not need to travel to an office to begin the conversation. The appointment is a medical evaluation, with time to discuss your history, questions, and next steps.

Mitochondrial disease appears on the Georgia Department of Public Health qualifying conditions list as a qualifying condition. Listing a condition does not guarantee that every patient should use cannabis. A physician makes an individual certification decision. Under Georgia law, only fully licensed physicians with a principal practice location in Georgia can evaluate and manage patients for certification. After that, Georgia's program handles state verification and the issuance of Medical Cannabis Cards separately. Only registered patients can legally access medical cannabis after completing the state process.

Book through Calendly, receive an eVisit link from our team, and attend your telemedicine visit. Payment is collected through eVisit after the visit. If the physician determines that you do not qualify, any consultation fee you paid will be refunded.

Understanding mitochondrial disease

The National Institute of Neurological Disorders and Stroke describes mitochondrial disorders as conditions affecting mitochondria, the energy-producing structures within cells. Different disorders can affect different organs, including muscles, the brain, the heart, and the eyes. Symptoms and their distribution vary between people, as they do across several neurological disorders. See NINDS mitochondrial disorders information for general education.

A broad description of mitochondrial dysfunction is not a substitute for your own diagnosis. Bring the name of the condition diagnosed by your treating clinician and explain what you understand about it. If your records use a different name, ask how that diagnosis relates to the term mitochondrial disease.

GMMC's consultation does not replace your specialist's ongoing medical care. It is not a genetic diagnostic service or a promise to change the underlying disease, even though mitochondrial disease can affect the brain, nervous system, and nerve cells. Tell the evaluating physician who manages your care and what follow-up is already planned.

What a medical cannabis consultation can address

Use the visit to explain what led you to consider medical cannabis. What is the question you most want answered? Are you seeking clarification about eligibility, discussing a symptom, or trying to understand the state card process? Specific questions make the conversation more useful than a general request for approval.

Describe your physical symptoms in your own words. Explain when they occur and how they affect everyday activities. If chronic pain, fatigue, intractable pain, or another concern is relevant to your history, describe it without assuming that it automatically qualifies you or predicts a treatment response.

You may also want to mention peripheral neuropathy or cognitive decline if those symptoms are affecting daily function.

Discuss your current treatment plans and other medications with the physician. Bring information about prescriptions, over-the-counter products, supplements, and any prior use of cannabis products. Do not change treatment solely because you scheduled this consultation.

Eligibility is different from effectiveness

Georgia program eligibility is a regulatory question. Whether a product is appropriate for an individual is a clinical question. These should not be treated as the same decision.

This page does not claim that medical marijuana repairs mitochondria, reverses mitochondrial disease, prevents cell death, or slows disease progression. It does not provide a dose or promise to alleviate symptoms, including symptoms discussed in conditions such as multiple sclerosis or Parkinson's disease. Questions about potential benefit, risks, and interactions belong in an individual medical discussion.

Laboratory findings, preclinical models, and mouse models cannot by themselves establish an effective treatment for people. If you bring an article or clinical trials information, ask what it actually studied and whether it applies to your diagnosis. Articles about the endocannabinoid system, spasticity symptoms, or other neurological mechanisms still need to be evaluated for relevance to the patient's diagnosis. Further research and your own clinical circumstances matter.

What preclinical mitochondrial research shows

A 2024 Nature Communications study tested CBD in two mouse models of Leigh syndrome and in patient-derived skin cells. Researchers reported longer survival and changes in neurological signs in mice, alongside improved function in cultured cells. They investigated PPARγ signaling and inflammatory and oxidative processes. The CBD dose tested did not directly restore mitochondrial respiration in the models. This was preclinical research, not a trial showing that cannabis treats mitochondrial disease in adults. Neuroprotective findings in laboratory models do not establish human benefit, safety or a recommended product.

Research into symptom relief remains a subject for clinical discussion, rather than a proven outcome. Robust clinical evidence for cannabis in mitochondrial disease remains limited. Neither these findings nor anecdotes establish a cure or show that cannabinoids repair mitochondria. Studies in multiple sclerosis, Parkinson’s disease or Alzheimer’s disease cannot be assumed to apply to your diagnosis.

Questions to bring to the physician

What information do you need to evaluate my diagnosis?
How does my existing medical history affect your assessment?
What uncertainties should I understand?
Is research discussed online about Alzheimer's disease or amyotrophic lateral sclerosis relevant to my specific diagnosis?
How would this discussion fit with my specialist's medical care?
What happens if you decide certification is not appropriate?
If certification is approved, what state steps are required to legally possess medical cannabis?
If I am certified, what are my next steps?

You can write down these questions before your appointment. You do not need to arrive with a particular product or treatment decision already made.

Safety and medication interactions

Responses and tolerance can differ between patients; another person’s experience cannot predict yours. The FDA describes CBD risks including liver injury, sleepiness, mood changes and interactions with medicines. Alcohol or other medicines that slow brain activity can increase sedation. Unapproved CBD products have not been reviewed for effectiveness, appropriate dosing or safety, and their labels or quality may be unreliable. Discuss prescriptions and supplements with your physician before considering a product.

Prepare for your private phone visit

Gather available records that document your diagnosis, recent relevant notes, and a medication list. Follow the team's instructions for providing information through the appropriate visit process. Please do not put medical records or sensitive health information in public website forms or chat. If you have already started the process, keep your state registry documentation handy.

Keep a short timeline of your condition nearby. Note the questions you want to prioritize, the care you currently receive, any questions about lawful possession after approval, and any previous experience you want to discuss. This helps you explain your situation clearly during a 15-minute consultation.

Choose a quiet place for the phone visit. Check the instructions sent by our team and make sure you can be reached for your scheduled appointment. If you need booking help or cannot access the link, contact GMMC.

How booking and payment work

1. Schedule on Calendly

Choose an available time for your $100 consultation. GMMC serves adults across Georgia, including Atlanta, Stockbridge, and other communities statewide. Scheduling a visit does not make marijuana legal for general use in Georgia. Calendar availability determines which appointment times can be booked.

2. Receive your eVisit link

Our team sends the eVisit link after you book. Calendly is the scheduling step; eVisit supports the telemedicine visit and payment process. Review the instructions before your appointment.

3. Attend the consultation

Speak with a Georgia-licensed physician about your history and the reason for your evaluation. The physician evaluates your diagnosis and, if appropriate, can manage patients within the certification process allowed by Georgia law. Booking an appointment does not guarantee approval.

4. Pay after your visit through eVisit

The $100 consultation fee is collected through eVisit after the telemedicine visit. If the physician determines that you do not qualify, GMMC refunds any consultation fee paid. There is no merchandise to return. Read our consultation refund policy.

Medical cannabis card and next steps

Physician certification and receiving a physical state card are separate parts of the process, and neither is the same as the process used to purchase medical cannabis. Do not treat an appointment confirmation as a state authorization. Follow the instructions provided if you are certified.

State card fees are separate from the GMMC consultation fee. For the current fee breakdown and payment explanation, visit pricing and fees. Our Get Your Card guide explains the next steps in more detail.

For current information about authorized dispensaries and pharmacies, consult the Georgia Access to Medical Cannabis Commission and the Georgia Board of Pharmacy.

For official Medical Cannabis Patient Registry requirements, use Georgia DPH patient and caregiver information. The state website is the source for current documentation, state payment, and card-status instructions. Georgia Access resources and the Medical Cannabis Commission also explain where state licensed medical cannabis may be obtained.

Current Georgia card and possession requirements

The Georgia Access to Medical Cannabis Commission lists 18 qualifying conditions, including mitochondrial disease. Physician certification is required for registry access. Registered patients and caregivers with a valid card may possess up to 12,000 milligrams of THC in authorized medical cannabis products kept in manufacturer-labeled pharmaceutical containers. The limit measures milligrams of THC, rather than a volume of oil. Smoking and home cultivation remain prohibited.

Authorized products are sold through licensed dispensaries or authorized independent pharmacies. The current Medical Cannabis Patient Registry name replaced the former Low THC Oil Registry name following the July 1, 2026 program changes. An unexpired card remains valid despite the name change.

The DPH patient guide requires identity and Georgia residency documentation. State card fees are $30 plus a $3.75 online service fee. The card is valid for five years. Allow up to 10 business days after state payment is processed; UPS delivery requires a signature. These fees and steps are separate from the GMMC consultation.

Frequently asked questions

Does mitochondrial disease automatically qualify me?

Mitochondrial disease is a listed qualifying condition under Georgia law, but certification still requires the physician's individual assessment. A diagnosis alone is not a guarantee of approval or a recommendation for a particular product. Other diagnoses have their own criteria. Review the qualifying conditions guide rather than assuming that one condition's rules apply to another.

Do you see children with mitochondrial disease?

No. GMMC's service is adults-only, age 18 and older. Information about another program or another provider's pediatric services does not change our clinic's scope.

Do I have to pay on Calendly?

No. Calendly is for booking. Your consultation fee is collected through eVisit after your telemedicine visit.

What if I do not qualify?

If the physician determines that you do not qualify for medical cannabis certification, GMMC refunds any consultation fee you paid. This is a consultation service, not a merchandise purchase.

Can I book from elsewhere in Georgia?

Yes. We serve adults statewide through private phone consultations. Choose an available appointment on Calendly and follow the eVisit instructions sent by our team. Patients across Georgia must still follow state and federal law when seeking certification and access.

Can this consultation replace my specialist?

No. Continue working with your treating clinicians. This visit addresses medical cannabis evaluation and certification considerations, rather than replacing ongoing specialist care. It is not a substitute for care in a hospice program or another health care institution.

Where can I ask a general booking question?

Use our contact page. See the FAQ page for more scheduling and payment answers.

Georgia medical cannabis eligibility and other diagnoses

Mitochondrial disease is the focus of this page. Georgia's list also includes neurological conditions such as amyotrophic lateral sclerosis (ALS), sometimes called Lou Gehrig's disease, multiple sclerosis, Parkinson's disease, Alzheimer's disease, and Tourette syndrome. These are separate diagnoses; they should not be used interchangeably with mitochondrial disease.

Autism spectrum disorder has age-dependent state criteria, while GMMC evaluates adults only. Post traumatic stress disorder has its own trauma and adult-age criteria, involving direct exposure to or witnessing trauma. Severe peripheral neuropathy, intractable pain, and sickle cell disease are other categories on the state list. A person should discuss the actual diagnosis documented in their medical records, rather than selecting a label because it appears on a website.

Our qualifying conditions guide explains the full list in the context of receiving health care through the proper channels, including inflammatory bowel disease, lupus, epidermolysis bullosa, qualifying cancer, and hospice program participation. Cancer criteria distinguish metastatic skin cancer from other skin cancer. Stage III HIV has a specific requirement. The current DPH list is the source for these distinctions.

Caregiver questions and access to medical cannabis

If you need assistance, tell the team what help you need with scheduling or accessing your visit instructions. Assistance with a consultation is different from formal caregiver authorization under the state program. A registered caregiver may have responsibilities involving purchasing, possessing, or administering medical cannabis for the patient.

Being a family member does not by itself establish registry authorization. Ask the state about requirements that apply to an individual authorized as a caregiver, a legal custodian, or a health care institution. Use official instructions instead of assuming that an appointment allows an unauthorized person to purchase or possess a product.

Questions about dispensaries licensed by the state, authorized pharmacies, and available cannabis products belong with the appropriate official resources. The Georgia Access to Medical Cannabis Commission provides information about regulated access. GMMC provides the consultation service; it does not supply products.

Keep treatment questions focused on your diagnosis

Research discussions about neurodegenerative diseases and neurodegenerative disorders can involve different populations and different outcomes. A study in Alzheimer's disease does not establish the same result in mitochondrial disease. Ask whether evidence involves people with your diagnosis, rather than relying on a shared reference to neurological disorders.

Whether your existing care is provided through neurology, genetics, internal medicine, or another specialty, tell the evaluating physician how the clinicians coordinate your treatment. Your appointment should add a clear evaluation conversation to that history.

Book your evaluation

If you are an adult Georgia patient with mitochondrial disease and want to discuss eligibility, choose a time for your $100 private 15-minute phone consultation. Your physician will review whether mitochondrial disease is the relevant qualifying condition and explain the state process needed to access care.

Approved patients may obtain only permitted cannabis products through the state's regulated system.